Viewing nowCombinationJardimet Tablet 12.5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.

MFDS item code 202302630 · Approved 2023.09.04 · Insurance code 644915230
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adult patients with Type 2 diabetes, as an adjunct to diet and exercise. The combination of empagliflozin and metformin is particularly suitable for patients whose blood sugar is not adequately controlled. In patients with cardiovascular disease, caution is required regarding the impact on the occurrence of cardiovascular events, and professional guidance should be consulted. Considering these points, this medication is used to assist in the management of blood sugar in diabetic patients and to improve their health status.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can cause a rare but very serious side effect known as severe lactic acidosis, and should not be used in patients with impaired kidney function, serious infections, or dehydration. Caution is also necessary when taking this medication with other diabetes drugs such as insulin or sulfonylureas, as it may increase the risk of hypoglycemia. Patients with a certain level of reduced kidney function, acute heart failure, acute myocardial infarction, or those facing specific acute illnesses or surgeries should not take this medication. During the course of this medication, regular kidney function tests should be performed, especially in elderly patients or those with slightly reduced kidney function. Patients at risk of fluid loss, such as those with severe vomiting or diarrhea, should consider temporarily discontinuing this medication. This medication may increase the risk of urinary tract infections and genital infections, so if symptoms of infection occur, one should immediately inform healthcare professionals and seek treatment. Pregnant women, those who may become pregnant, and nursing mothers should not take this medication, and if breastfeeding, should discontinue nursing. Excessive alcohol consumption should be avoided while taking this medication, as alcohol can increase the risk of side effects. Additionally, this medication may increase the risk of hypoglycemia when used with other blood sugar-lowering drugs, so dosage adjustments should be discussed with a healthcare professional. In preparation for surgery, this medication should be discontinued 48 hours before the procedure, and it can be resumed only after kidney function has returned to normal post-surgery. This medication is not recommended for children under 18, and dosage adjustments may be necessary for elderly patients based on their kidney function. Finally, during the course of this medication, if any symptoms change or unusual reactions occur, one should immediately consult a doctor to receive appropriate measures.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, at room temperatures between 1 to 30 degrees Celsius. This will help maintain the efficacy of the medication and prevent degradation.
Pinkish white, biconvex, oval film-coated tablet
60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 60 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.